Basic science mouse study of a common protein target shared in multiple cancers warrants further assessment in humans. No treatments on the horizon but this epitomizes good scientific research.

Medical Mythbusting Commentary for January 23, 2020

New scientific breakthrough could lead to ‘one-size-fits-all’ cancer treatment

Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1